Laboratory Corporation of America® Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance

Go back to Laboratory Corporation of America® Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance

Laboratory Corporation of America (LH) PT Raised to $150 at Canaccord Genuity

February 17, 2017 10:19 AM EST

Canaccord Genuity raised its price target on Laboratory Corporation of America (NYSE: LH) to $150.00 (from $140.00) while maintaining a Buy rating. 4Q adjusted EPS of $2.15 beat the Street's $2.13. Net revenuess of $2,387M beat the Street's $2,350M.

Analyst Mark Massaro commented, "LH bounced back... More

Laboratory Corp. of America (LH) PT Raised to $139 at Mizuho on Following 4Q Results

February 17, 2017 8:15 AM EST

Mizuho Securities analyst Ann Hynes reiterates Neutral rating and raises price target on Laboratory Corp. of America Holdings (NYSE: LH) to $139 (from $135), noting improving Covance metrics and free cash flow, as the company reported 2016 fourth quarter results and 2017 guidance in-line with... More

Lab Corp. (LH) Tops Q4 EPS by 2c; Guides In-Line

February 16, 2017 6:58 AM EST

Lab Corp. (NYSE: LH) reported Q4 EPS of $2.15, $0.02 better than the analyst estimate of $2.13. Revenue for the quarter came in at $2.39 billion versus the consensus estimate of $2.35 billion.

GUIDANCE:

Lab Corp. sees FY2017 EPS of $9.35-$9.75, versus the consensus of... More